new YORK (Reuters Health) – a study in
Australia showed that consumption of fish oil during the
first six months of life enhances the profile of acidic grades
omega-3 polyunsaturated (PUFA, by its English name), but not
reduces the risk of developing allergies.
“the emerging evidence of the protective effects of the
chain PUFA long during pregnancy, but not in the period
postnatal care, suggest that optimize the PUFA profile n-3
it would be desirable, especially through the promotion of consumption
maternal of these substances during pregnancy (and) perhaps together
with breastfeeding”, writes in the journal Pediatrics team of
Dr. Sarah L. Prescott, the unit of the Royal Hospital of
Perth, of the University of Western Australia.
The Dr. Ellen l. preterm, of the University of New
Mexico”, in Albuquerque, United States, who did not participate of the
Studio, coincided.
” is an essay correctly and with results that match with
the findings of clinical trials prior to know. the use
prenatal supplements is the way to go, although the
results of prenatal tests differ “, said.
in Perth, 420 babies with atopic high-risk study
received a daily supplement of fish oil with 280 mg
of Docosahexaenoic acid (DHA) and 110 mg of acid
Eicosapentaenoic (EPA) or a placebo (olive oil).
at six months, babies treated with fish oil
had significantly high levels of DHA and EPA, and levels
lowest of arachidonic acid (AA) in erythrocytes. but that not
meant a decrease in the risk of developing allergies in
the first year of life.
“”Hoewel niveaus van n-3 PUFA tot zes maanden van het leven
ze werden geassocieerd met een vermindering van het risico van het ontwikkelen van
eczeem en piepende ademhaling, relatie met eczeem verloren
relevantie met multiple comparisons”, een overzicht van de apparatuur.
“interfractiewerkgroep vergelijkingen bleek met name neen
verschillen in het voorkomen van allergieën, met inbegrip van de
sensibilisatie, eczeem, astma of voedsel allergieën”,
toegevoegd de auteurs.
vroeggeboorte beschouwd als “interessant dat het team vond
enig bewijs van voordelen in de analyse van de wrijvingscoëfficiënt
groep van zuigelingen die had ontvangen meer dan 75 procent van de
doses”.
“is zeer moeilijk te bereiken de bevolking om te consumeren olie van
vissen regelmatig, op een manier die maakt me gelukkig om te zien dat de
team geanalyseerd de naleving van de behandeling”, toegevoegde.
en said: “think that the tendency to have an allergy appears
in prenatal life and with maternal supplementation is
would modify the programming of the immune disease in the
development”.
team recently conducted a meta-analysis of the effect
use prenatal supplementation with omega-3 in markers
inflammatory and disease allergic. analysis included
five randomized controlled on 949 people.
results, published in BJOG in 2011, showed
that the use of the PUFA n-3 during pregnancy reduces the
annual prevalence of positive skin test results of
sensitivity to egg (two studies) and the childhood asthma (two
trials), as well as significantly lower levels of
interleukin 13 in the blood of lace.
use of supplements during breastfeeding not
warned astma, voedselallergie of atopy.
tot nu toe, zoals geloofde te vroeg geboren, “klinische proeven
prenatale bleek niet noodzakelijkerwijs resultaten zo
definitief aan te bevelen dat alle vrouwen gebruiken
hoge doses van DHA om te voorkomen dat anti”.
zelfs zo beschouwd die resultaten van langdurige follow-up
sommige van deze klinische tests “kan wijzigen de
praktijk” ten slotte.
Bron: kindergeneeskunde, 2012